Response to "Be alert to leukocyte antibodies when prescribing granulocyte transfusions"
Transfusion
.
2019 Jun;59(6):2174-2175.
doi: 10.1111/trf.15258.
Authors
Thomas H Price
1
2
,
Jeffrey McCullough
3
,
Ronald G Strauss
4
5
,
Paul M Ness
6
,
Taye H Hamza
7
,
Ryan W Harrison
8
,
Susan F Assmann
7
Affiliations
1
Department of Medicine, University of Washington, Seattle, Washington.
2
Bloodworks Northwest, Seattle, Washington.
3
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota.
4
Department of Pathology, University of Iowa Hospital, Iowa City, Iowa.
5
LifeSource/ITxM, Chicago, Illinois.
6
Department of Pathology, Division of Transfusion Medicine, Johns Hopkins Hospital, Baltimore, Maryland.
7
New England Research Institutes, Watertown, Massachusetts.
8
Corrona LLC, Waltham, Massachusetts.
PMID:
31161668
DOI:
10.1111/trf.15258
No abstract available
Publication types
Letter
Comment
MeSH terms
Granulocytes*
Immunologic Tests
Leukocyte Transfusion*